Ardsley Advisory Partners’s Correvio Pharma Corp. Ordinary Shares (Canada) CORV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-12,500
Closed -$25K 225
2019
Q3
$25K Hold
12,500
0.01% 131
2019
Q2
$27K Buy
12,500
+2,134
+21% +$5.45K 0.01% 147
2019
Q1
$33K Buy
+10,366
New +$33.5K 0.01% 129
2017
Q4
Sell
-36,200
Closed -$77K 192
2017
Q3
$77K Sell
36,200
-3,800
-10% -$12.9K 0.01% 129
2017
Q2
$180K Hold
40,000
0.04% 130
2017
Q1
$120K Buy
40,000
+11,100
+38% +$32.7K 0.02% 146
2016
Q4
$80K Hold
28,900
0.02% 121
2016
Q3
$90K Hold
28,900
0.02% 150
2016
Q2
$148K Buy
28,900
+5,000
+21% +$24K 0.03% 138
2016
Q1
$98K Buy
23,900
+500
+2% +$2.67K 0.02% 135
2015
Q4
$190K Hold
23,400
0.03% 131
2015
Q3
$197K Hold
23,400
0.05% 132
2015
Q2
$220K Buy
23,400
+8,400
+56% +$78.3K 0.03% 142
2015
Q1
$139K Buy
+15,000
New +$144K 0.02% 176

Other funds holding CORV